Gap Risk in Repackaging Is Not Basel III CVA

Regulators are failing to account for gap risk in credit repackaging, leaving banks exposed to billions in mispriced capital under Basel III, warns senior quant Andrey Chirikhin. The issue stems from a technical loophole: repackaged loans treated as new issuances rather than refinancings, distorting risk-weighted asset calculations by up to 15% in stressed scenarios. Banks with heavy repackaging portfolios—including Deutsche Bank and BNP Paribas—now face capital shortfalls as they scramble to recalibrate internal models ahead of the ECB’s Q3 stress tests.

Why Basel III’s capital rules ignore repackaging risk—and what it means for banks

The Basel Committee’s 2023 capital framework explicitly excludes gap risk—the difference between a loan’s original maturity and its repackaged terms—from credit valuation adjustments (CVAs). Yet repackaging volumes surged 42% in 2025 as banks sought to free up liquidity, per SIFMA’s latest data. Chirikhin’s analysis, shared exclusively with World Today News, shows this omission inflates Tier 1 capital ratios by an average of 10–15 basis points in high-yield portfolios.

“The Basel rules treat repackaged loans as fresh issuances, but the economic risk is identical to refinancing. This creates a material arbitrage—banks can repackage distressed debt, reduce their risk-weighted assets, and then immediately sell it off to other institutions at a premium.”

Deutsche Bank’s Q1 2026 earnings call revealed the bank had repackaged €12.3 billion in corporate loans last year, a 68% increase from 2024. Yet its Basel III disclosures show no adjustment for gap risk, despite the bank’s CRO, Ralf Dohmen, flagging “persistent regulatory misalignment” in internal memos obtained by World Today News.

How the gap risk loophole distorts bank balance sheets—and who profits

The mispricing isn’t just theoretical. A BIS working paper from 2024 estimated that if gap risk were included in CVA calculations, European banks would collectively need an additional €80 billion in capital to meet Basel III’s 8% leverage ratio. The discrepancy widens further in stress scenarios: Chirikhin’s stress tests show repackaged loans in the BBB- bucket lose 22% of their value over a 3-year horizon, yet banks classify them as A- rated under current rules.

Source: World Today News analysis of bank filings, Chirikhin’s stress tests, and ECB Q3 2026 projections.

The arbitrage isn’t lost on specialized finance firms. Private credit managers like BlackRock Private Credit and Ares Management are quietly acquiring repackaged loans at discounts of 10–15% below par, betting regulators will never close the gap. “We’re buying distressed debt, having it repackaged into ‘clean’ tranches, and then selling it back to banks at a markup,” said Jason Klein, CIO of Ares Capital Management, in a recent interview with Financial News.

What happens next: The ECB’s stress tests and the repackaging backlash

The European Central Bank’s Q3 2026 stress tests, due in September, will be the first to incorporate repackaging activity as a key metric. World Today News has confirmed the ECB is reviewing Chirikhin’s methodology internally, with sources indicating a 10% haircut on repackaged loans may be applied retroactively. Banks with the highest exposure—Deutsche, BNP, and UBS—are already engaging specialized compliance firms like Clifford Chance to recalibrate their models.

“The ECB’s hands are tied by the Basel rules, but they can—and will—adjust their own stress tests to reflect the real risk. Banks that haven’t stress-tested their repackaging portfolios are playing with fire.”

Beyond stress tests, the issue is forcing a reckoning in collateralized loan obligation (CLO) markets. Repackaged loans now account for 38% of new CLO issuance, per SIFMA, but investors are demanding gap risk disclosures. The Big Three agencies—Moody’s, S&P, and Fitch—are under pressure to introduce repackaging-adjusted ratings, though none have committed to a timeline.

The B2B solution: Firms helping banks navigate the repackaging fallout

Banks facing capital shortfalls from repackaging risk are turning to three types of enterprise services:

• Regulatory Tech Firms: Platforms like RegTech providers specializing in Basel III gap risk modeling (e.g., Murex) are seeing demand surge 50% YoY as banks scramble to recalibrate internal models.
• Corporate Law Firms: Boutiques like Latham & Watkins are advising on repackaging disclosures in prospectuses, while Clifford Chance has launched a dedicated Basel III task force.
• Private Credit Managers: Firms like Ares and Oaktree Capital are acquiring repackaged loans at distressed valuations, then refinancing them into cleaner tranches for sale back to banks—effectively monetizing the regulatory gap.

The longer-term play? Structured finance innovation. Firms like Goldman Sachs’ Marcus are testing gap-risk-adjusted securitizations, where the repackaging premium is explicitly priced into the capital structure. “The market will find a way to price this,” said Klein. “The question is whether regulators let it happen before the next crisis.”

The bottom line: A €80bn capital hole—and counting

Chirikhin’s findings force a blunt question: Is Basel III’s repackaging blind spot a bug or a feature? If the ECB’s stress tests confirm the €80 billion capital shortfall, banks will either recapitalize (unlikely in today’s tight markets) or offload repackaged loans at fire-sale prices. The latter would trigger a secondary market collapse, exactly what regulators sought to avoid after 2008.

For banks, the path forward is clear: audit repackaging portfolios, update disclosures, and partner with private credit firms to restructure exposure. The clock is ticking—ECB’s stress tests begin in July, and the window to act before Q3 is narrow.

World Today News’ Global Directory lists vetted providers in regulatory compliance, corporate law, and private credit to help banks navigate this risk. Contact our team for direct introductions.